Is VBI Vaccines Stock a Good Investment?
VBI Vaccines Investment Advice | VBIVQ |
- Examine VBI Vaccines' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research VBI Vaccines' leadership team and their track record. Good management can help VBI Vaccines navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact VBI Vaccines' business and its evolving consumer preferences.
- Compare VBI Vaccines' performance and market position to its competitors. Analyze how VBI Vaccines is positioned in terms of product offerings, innovation, and market share.
- Check if VBI Vaccines pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about VBI Vaccines' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in VBI Vaccines stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if VBI Vaccines is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine VBI Vaccines Stock
Researching VBI Vaccines' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if VBI Vaccines is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding VBI Vaccines' research are outlined below:
| VBI Vaccines generated a negative expected return over the last 90 days | |
| VBI Vaccines has high historical volatility and very poor performance | |
| VBI Vaccines has some characteristics of a very speculative penny stock | |
| VBI Vaccines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 8.68 M. Net Loss for the year was (92.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| VBI Vaccines generates negative cash flow from operations | |
| VBI Vaccines has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: VBI Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission |
VBI Vaccines Quarterly Good Will |
|
Basic technical analysis of VBI Stock
As of the 25th of December, VBI Vaccines has the Risk Adjusted Performance of (0.03), market risk adjusted performance of (1.10), and Standard Deviation of 29.37. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of VBI Vaccines, as well as the relationship between them.Understand VBI Vaccines' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing VBI Vaccines' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (1.10) | |||
| Mean Deviation | 13.86 | |||
| Coefficient Of Variation | (2,047) | |||
| Standard Deviation | 29.37 | |||
| Variance | 862.36 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (1.49) | |||
| Total Risk Alpha | (2.72) | |||
| Treynor Ratio | (1.11) | |||
| Maximum Drawdown | 177.78 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 60.0 | |||
| Skewness | 1.44 | |||
| Kurtosis | 5.8 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (1.10) | |||
| Mean Deviation | 13.86 | |||
| Coefficient Of Variation | (2,047) | |||
| Standard Deviation | 29.37 | |||
| Variance | 862.36 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (1.49) | |||
| Total Risk Alpha | (2.72) | |||
| Treynor Ratio | (1.11) | |||
| Maximum Drawdown | 177.78 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 60.0 | |||
| Skewness | 1.44 | |||
| Kurtosis | 5.8 |
Consider VBI Vaccines' intraday indicators
VBI Vaccines intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VBI Vaccines stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
VBI Vaccines time-series forecasting models is one of many VBI Vaccines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VBI Vaccines' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
VBI Stock media impact
Far too much social signal, news, headlines, and media speculation about VBI Vaccines that are available to investors today. That information is available publicly through VBI media outlets and privately through word of mouth or via VBI internal channels. However, regardless of the origin, that massive amount of VBI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of VBI Vaccines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of VBI Vaccines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to VBI Vaccines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive VBI Vaccines alpha.
VBI Vaccines Corporate Management
| FRCPC MD | Chief Officer | Profile | |
| Avi Mazaltov | Global SciVac | Profile | |
| Misha Nossov | Senior Europe | Profile | |
| David Anderson | Chief Officer | Profile |
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.